Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program (Q28165707)
Jump to navigation
Jump to search
scientific article (publication date: October 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program |
scientific article (publication date: October 2003) |
Statements
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program (English)
0 references
Matthew R. Weir
Rhoda S. Sperling
October 2003
0 references
146
0 references
4
0 references
591-604
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference